Agios Pharmaceuticals (AGIO)

Agios Securities Corporation • Agios Limited • Agios International Sarl • Agios Netherlands B.V. • Agios Germany GmbH • Agios Italy S.R.L. • Agios France SARL ...

AGIO stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$66.00

Low target

$57.00

High target

$75.00

Latest filings (excl ownership)

View all

8-K

Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio

13 Jan 25

8-K

Regulation FD Disclosure

31 Oct 24

Agios Reports Business Highlights and Third Quarter 2024 Financial Results

1 Aug 24

Agios Reports Business Highlights and Second Quarter 2024 Financial Results

1 Aug 24

8-K

Submission of Matters to a Vote of Security Holders

20 Jun 24

8-K

Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty

2 May 24

Agios Reports Business Highlights and First Quarter 2024 Financial Results

2 May 24

Transcripts

View all

AGIO

Earnings call transcript

2024 Q3

31 Oct 24

AGIO

Earnings call transcript

2024 Q2

1 Aug 24

AGIO

Earnings call transcript

2024 Q1

2 May 24

AGIO

Earnings call transcript

2023 Q4

15 Feb 24

AGIO

Earnings call transcript

2023 Q3

2 Nov 23

AGIO

Earnings call transcript

2023 Q2

3 Aug 23

AGIO

Earnings call transcript

2023 Q1

4 May 23

AGIO

Earnings call transcript

2022 Q4

23 Feb 23

AGIO

Earnings call transcript

2022 Q3

4 Nov 22

AGIO

Earnings call transcript

2022 Q2

7 Aug 22

Latest ownership filings

View all

Theodore James Jr. Washburn

5 Feb 25

SC 13G/A

Farallon Capital Partners, L.P.

Notice of proposed sale of securities

ARMISTICE CAPITAL, LLC

14 Nov 24

Theodore James Jr. Washburn

Notice of proposed sale of securities

8 Nov 24

Financial summary

Financial statements Chart AGIO financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	253.73 mm	253.73 mm	253.73 mm	253.73 mm	253.73 mm	253.73 mm
Cash burn (monthly)	(no burn)	(no burn)	(no burn)	(no burn)	28.07 mm	27.43 mm
Cash used (since last report)	n/a	n/a	n/a	n/a	125.07 mm	122.20 mm
Cash remaining	n/a	n/a	n/a	n/a	128.66 mm	131.53 mm
Runway (months of cash)	n/a	n/a	n/a	n/a	4.6	4.8

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

AGIO institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	210	208	+1.0%
Opened positions	28	53	-47.2%
Closed positions	26	30	-13.3%
Increased positions	78	48	+62.5%
Reduced positions	67	79	-15.2%

13F shares	Current	Prev Q	Change
Total value	2.33 tn	2.29 tn	+2.0%
Total shares	74.48 mm	73.24 mm	+1.7%
Total puts	464.90 k	247.00 k	+88.2%
Total calls	402.90 k	275.00 k	+46.5%
Total put/call ratio	1.2	0.9	+28.5%

Largest owners	Shares	Value	Change
Celgene European Investment	7.12 mm	$242.07 mm	0.0%
Farallon Capital Management	5.66 mm	$251.51 bn	+0.1%
Vanguard	5.55 mm	$246.41 bn	+0.9%
Farallon Capital Partners	5.44 mm	$251.82 mm	+36.5%
BlackRock	5.02 mm	$223.12 bn	NEW
BBBOF BB Biotech	4.00 mm	$0.00	0.0%
BLVGF Bellevue	3.74 mm	$165.99 bn	-3.7%
T. Rowe Price	2.83 mm	$125.85 mm	+2.0%
STT State Street	2.33 mm	$103.59 bn	+10.2%
Armistice Capital	2.21 mm	$98.06 bn	+6.2%

Largest transactions	Shares	Bought/sold	Change
BlackRock	5.02 mm	+5.02 mm	NEW
BLK BlackRock	0.00	-4.86 mm	EXIT
Farallon Capital Partners	5.44 mm	+1.45 mm	+36.5%
Polar Capital	1.00 mm	+1.00 mm	NEW
Vestal Point Capital	760.00 k	+760.00 k	NEW
Dimensional Fund Advisors	1.56 mm	-633.90 k	-28.9%
Schonfeld Strategic Advisors	31.02 k	-433.10 k	-93.3%
Rock Springs Capital Management	699.39 k	-344.87 k	-33.0%
Laurion Capital Management	0.00	-248.40 k	EXIT
MS Morgan Stanley	348.97 k	-247.70 k	-41.5%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

AGIO insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
5 Feb 25	Theodore James Jr. Washburn	Common stock	Sell	Dispose S	No	Yes	34.39	2,272	78.13 k	5,437
1 Feb 25	Theodore James Jr. Washburn	Common stock	Option exercise	Acquire M	No	No	0	6,896	0.00	7,709
1 Feb 25	Theodore James Jr. Washburn	RSU Common stock	Option exercise	Dispose M	No	No	0	6,896	0.00	0
6 Jan 25	Tsveta Milanova	Common stock	Sell	Dispose S	No	Yes	32.18	2,804	90.23 k	18,906
3 Jan 25	Tsveta Milanova	Common stock	Option exercise	Acquire M	No	No	0	8,476	0.00	21,710
3 Jan 25	Tsveta Milanova	RSU Common stock	Option exercise	Dispose M	No	No	0	8,476	0.00	8,475
11 Dec 24	Scadden David	Common stock	Sell	Dispose S	No	Yes	46.28	200	9.26 k	15,483
11 Dec 24	Scadden David	Common stock	Option exercise	Acquire M	No	Yes	18.09	200	3.62 k	15,683
11 Dec 24	Scadden David	Stock options Common stock	Option exercise	Dispose M	No	Yes	18.09	200	3.62 k	29,107
8 Nov 24	Theodore James Jr. Washburn	Common stock	Sell	Dispose S	No	No	56.09	772	43.30 k	813